EU HTA Advanced Academy
before
ISPOR Europe
Two intensive days of practical learning, real-world workshops and expert insights to prepare your organisation for the new era of Joint Clinical Assessments.
Virtual Kick-off
29 October 2026
In-person in Vienna
5–6 November 2026
Limited cohort
25–30 participants
WHO SHOULD ATTEND?
Market Access & Pricing
HEOR & Evidence
Regulatory & Medical Affairs
Clinical Development
Data Science & Biostatistics
Global & Regional Strategy
WHAT YOU’LL TAKE AWAY
Strategic Clarity
Navigate the EU HTA landscape and its impact on your product strategy.
Practical Skills
Apply JCA, JSC, PICO and evidence requirements to real-world scenarios.
Actionable Readiness
Build a clear roadmap from EU JCA to national HTA and market access.
AGENDA
Two intensive days in Vienna, just ahead of ISPOR Europe 2026 – the perfect opportunity to deepen your EU HTA expertise and enter the conference discussions well prepared.
The programme starts with a virtual kick-off, followed by focused in-person sessions combining expert insights, real-world cases and hands-on exercises.
Thursday 29 October (1 week before) · Virtual
- Alignment on objectives, agenda & expectations
- EU HTA Regulation overview: governance, EMA/JCA timelines & JCA scope
- Closing Q&A
Thursday 5 November · In-person — Day 1
- JSC: process, selection criteria & parallel JSC
- Practical: JSC case scenarios & briefing package
- PICO scoping in the JCA, with a PICOs simulation exercise
- Networking dinner
- Expert Keynote
Friday 6 November · In-person — Day 2
- JCA strategic planning: evidence requirements, national HTA, teamreadiness
- Incomplete dossiers: PICO reasoning & national considerations
- Exercise: planning a product’s journey from EMA/EU JCA to national HTA
- JCA statistical requirements: ITC methods & evidence expectations
- Expert Keynote